Works by Kauh, John

Results: 27

Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard?

Published in:

2011

By:

Kang, Hyunseok;
Kauh, John;
Kauh, John S

Publication type:

journal article

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.

Published in:

2016

By:

Saif, Muhammad;
Knost, James;
Chiorean, E.;
Kambhampati, Siva;
Yu, Danni;
Pytowski, Bronislaw;
Qin, Amy;
Kauh, John;
O'Neil, Bert;
Saif, Muhammad Wasif;
Knost, James A;
Chiorean, E Gabriela;
Kambhampati, Siva Rama Prasad;
Kauh, John S;
O'Neil, Bert H

Publication type:

journal article

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).

Published in:

2018

By:

Meropol, Neal J.;
Feng, Yang;
Grem, Jean L.;
Mulcahy, Mary F.;
Catalano, Paul J.;
Kauh, John S.;
Hall, Michael J.;
Saltzman, Joel N.;
George, Jr, Thomas J.;
Zangmeister, Jeffrey;
Chiorean, Elena G.;
Cheema, Puneet S.;
O'Dwyer, Peter J.;
Benson, III, Al B.;
George, Thomas J Jr;
O'Dwyer, Peter J;
Benson, Al B 3rd

Publication type:

journal article

Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base.

Published in:

Cancer (0008543X), 2014, v. 120, n. 4, p. 499, doi. 10.1002/cncr.28530

By:

Colbert, Lauren E.;
Hall, William A.;
Nickleach, Dana;
Switchenko, Jeffrey;
Kooby, David A.;
Liu, Yuan;
Gillespie, Theresa;
Lipscomb, Joseph;
Kauh, John;
Landry, Jerome C.

Publication type:

Article

The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 12, p. 2350, doi. 10.1002/cncr.28047

By:

Hall, William A.;
Colbert, Lauren E.;
Liu, Yuan;
Gillespie, Theresa;
Lipscomb, Joseph;
Hardy, Claire;
Kooby, David A.;
Prabhu, Roshan S.;
Kauh, John;
Landry, Jerome C.

Publication type:

Article

Fractionated radioimmunotherapy with <sup>90</sup>Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer.

Published in:

Cancer (0008543X), 2012, v. 118, n. 22, p. 5497, doi. 10.1002/cncr.27592

By:

Ocean, Allyson J.;
Pennington, Kenneth L.;
Guarino, Michael J.;
Sheikh, Arif;
Bekaii-Saab, Tanios;
Serafini, Aldo N.;
Lee, Daniel;
Sung, Max W.;
Gulec, Seza A.;
Goldsmith, Stanley J.;
Manzone, Timothy;
Holt, Michael;
O'Neil, Bert H.;
Hall, Nathan;
Montero, Alberto J.;
Kauh, John;
Gold, David V.;
Horne, Heather;
Wegener, William A.;
Goldenberg, David M.

Publication type:

Article

Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.

Published in:

Journal of Surgical Oncology, 2014, v. 109, n. 6, p. 556, doi. 10.1002/jso.23529

By:

Shaib, Walid L.;
Sharma, Rahul;
Brutcher, Edith;
Kim, Sungjin;
Maithel, Shishir K.;
Chen, Zhengjia;
Kooby, David A.;
Kauh, John;
Landry, Jerome;
El‐Rayes, Bassel F.

Publication type:

Article

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).

Published in:

Journal of Surgical Oncology, 2010, v. 101, n. 6, p. 476, doi. 10.1002/jso.21522

By:

Dhanasekaran, Renumathy;
Kooby, David A.;
Staley, Charles A.;
Kauh, John S.;
Khanna, Vinit;
Kim, Hyun S.

Publication type:

Article

Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center.

Published in:

Journal of Surgical Oncology, 2008, v. 98, n. 2, p. 81, doi. 10.1002/jso.21049

By:

Kooby, David A.;
Egnatashvili, Vasili;
Graiser, Michael;
Delman, Keith A.;
Kauh, John;
Wood, William C.;
Staley III, Charles A.

Publication type:

Article

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors.

Published in:

2017

By:

Tolcher, Anthony;
Berlin, Jordan;
Cosaert, Jan;
Kauh, John;
Chan, Emily;
Piha-Paul, Sarina;
Amaya, Alex;
Tang, Shande;
Driscoll, Kyla;
Kimbung, Richard;
Kambhampati, S.;
Gueorguieva, Ivelina;
Hong, David;
Tolcher, Anthony W;
Berlin, Jordan D;
Piha-Paul, Sarina A;
Kambhampati, S R Prasad;
Hong, David S

Publication type:

journal article

Examining Racial Disparities in Colorectal Cancer Care.

Published in:

Journal of Psychosocial Oncology, 2009, v. 27, n. 1, p. 59, doi. 10.1080/07347330802614840

By:

Berry, Jamillah;
Bumpers, Kevin;
Ogunlade, Vickie;
Glover, Roni;
Davis, Sharon;
Counts-Spriggs, Margaret;
Kauh, John;
Flowers, Christopher

Publication type:

Article

Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 12, p. 3384, doi. 10.1245/s10434-011-1775-3

By:

Patel, Sameer;
Kneuertz, Peter;
Delgado, Maria;
Kooby, David;
Staley, Charles;
El-Rayes, Bassel;
Kauh, John;
Sarmiento, Juan;
Hanish, Steven;
Cohen, Cynthia;
Farris, Alton;
Maithel, Shishir

Publication type:

Article

Differential Expression of ERCC1 in Pancreas Adenocarcinoma: High Tumor Expression is Associated with Earlier Recurrence and Shortened Survival after Resection.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 9, p. 2699, doi. 10.1245/s10434-011-1610-x

By:

Maithel, Shishir;
Coban, Ipek;
Kneuertz, Peter;
Kooby, David;
El-Rayes, Bassel;
Kauh, John;
Sarmiento, Juan;
Staley, Charles;
Volkan Adsay, N.

Publication type:

Article

Yttrium-90 Radioembolization for Unresectable Standard-chemorefractory Intrahepatic Cholangiocarcinoma: Survival, Efficacy, and Safety Study.

Published in:

CardioVascular & Interventional Radiology, 2013, v. 36, n. 2, p. 440, doi. 10.1007/s00270-012-0463-4

By:

Rafi, Shoaib;
Piduru, Sarat;
El-Rayes, Bassel;
Kauh, John;
Kooby, David;
Sarmiento, Juan;
Kim, Hyun

Publication type:

Article

COMMENTARY on Wang et al., “Pre‐operative chemotherapy with oral tegafur‐uracil and leucovorin for rectal cancer” (J Surg Oncol 89: 256–263).

Published in:

Journal of Surgical Oncology, 2005, v. 90, n. 2, p. 106, doi. 10.1002/jso.20262

By:

John Kauh

Publication type:

Article

Early Clinical Results from Chemoradiation with 5-Fluorouracil and Oxaliplatin for Locally Advanced Rectal Cancer.

Published in:

Clinical Cancer Update, 2008, v. 2, n. 1, p. 43, doi. 10.3816/CCU.2008.n.007

By:

Lawson, Joshua D.;
Kauh, John;
Koshy, Mary;
Staley, Charles;
Landry, Jerome

Publication type:

Article

c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589.

Published in:

PLoS ONE, 2010, v. 5, n. 4, p. 1, doi. 10.1371/journal.pone.0010376

By:

Kauh, John;
Songqing Fan;
Mingjing Xia;
Ping Yue;
Lily Yang;
Khuri, Fadlo R.;
Shi-Yong Sun

Publication type:

Article

Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.

Published in:

Cancer (0008543X), 2011, v. 117, n. 17, p. 4049, doi. 10.1002/cncr.26004

By:

Kauh, John;
Chanel-Vos, Chantal;
Escuin, Daniel;
Fanucchi, Michael P.;
Harvey, R. Donald;
Saba, Nabil;
Shin, Dong M.;
Gal, Anthony;
Pan, Lin;
Kutner, Michael;
Ramalingam, Suresh S.;
Bender, Laura;
Marcus, Adam;
Giannakakou, Paraskevi;
Khuri, Fadlo R.

Publication type:

Article

Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.

Published in:

Cancer (0008543X), 2010, v. 116, n. 16, p. 3903, doi. 10.1002/cncr.25264

By:

Ramalingam, Suresh S.;
Harvey, R. Donald;
Saba, Nabil;
Owonikoko, Taofeek K.;
Kauh, John;
Shin, Dong M.;
Sun, Shi-Yong;
Strychor, Sandra;
Tighiouart, Mourad;
Egorin, Merrill J.;
Fu, Haian;
Khuri, Fadlo R.

Publication type:

Article

A Black-White Comparison of the Quality of Stage-Specific Colon Cancer Treatment.

Published in:

Cancer (0008543X), 2010, v. 116, n. 3, p. 713, doi. 10.1002/cncr.24757

By:

Berry, Jamillah;
Caplan, Lee;
Davis, Sharon;
Minor, Patrick;
Counts-Spriggs, Margaret;
Glover, Roni;
Ogunlade, Vickie;
Bumpers, Kevin;
Kauh, John;
Brawley, Otis W.;
Flowers, Christopher

Publication type:

Article

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 245, doi. 10.1634/theoncologist.2016-0265

By:

Vahdat, Linda T.;
Layman, Rachel;
Yardley, Denise A.;
Gradishar, William;
Salkeni, Mohamad A.;
Joy, Anil Abraham;
Garcia, Agustin A.;
Ward, Patrick;
Khatcheressian, James;
Sparano, Joseph;
Rodriguez, Gladys;
Tang, Shande;
Gao, Ling;
Dalal, Rita P.;
Kauh, John;
Miller, Kathy

Publication type:

Article

Through the Looking Glass: The Evolution of Erythropoiesis-Stimulating Agent Use.

Published in:

Oncology (08909091), 2010, v. 24, n. 3, p. 269

By:

Harvey, R. Donald;
Khuri, Fadlo R.;
Kauh, John S.

Publication type:

Article

Management of Anal Cancer in the HIV-Positive Population.

Published in:

Oncology (08909091), 2005, v. 19, n. 12, p. 1634

By:

Kauh, John;
Koshy, Mary;
Gunthel, Clifford;
Joyner, Melissa M.;
Landry, Jerome;
Thomas, Jr., Charles R.

Publication type:

Article

LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.

Published in:

Investigational New Drugs, 2021, v. 39, n. 4, p. 1057, doi. 10.1007/s10637-021-01084-8

By:

Dowlati, Afshin;
Harvey, R. Donald;
Carvajal, Richard D.;
Hamid, Omid;
Klempner, Samuel J.;
Kauh, John Sae Wook;
Peterson, Daniel A.;
Yu, Danni;
Chapman, Sonya C.;
Szpurka, Anna M.;
Carlsen, Michelle;
Quinlan, Tonya;
Wesolowski, Robert

Publication type:

Article

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2017, v. 35, n. 4, p. 442, doi. 10.1007/s10637-016-0413-0

By:

LoRusso, Patricia;
Gounder, Mrinal;
Jalal, Shadia;
André, Valérie;
Kambhampati, Siva;
Loizos, Nick;
Hall, Jennifer;
Holzer, Timothy;
Nasir, Aejaz;
Cosaert, Jan;
Kauh, John;
Chiorean, E.

Publication type:

Article

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies.

Published in:

Investigational New Drugs, 2015, v. 33, n. 3, p. 652, doi. 10.1007/s10637-015-0230-x

By:

Smith, David;
Kalebic, Thea;
Infante, Jeffrey;
Siu, Lillian;
Sullivan, Daniel;
Vlahovic, Gordana;
Kauh, John;
Gao, Feng;
Berger, Allison;
Tirrell, Stephen;
Gupta, Neeraj;
Bacco, Alessandra;
Berg, Deborah;
Liu, Guohui;
Lin, Jianchang;
Hui, Ai-Min;
Thompson, John

Publication type:

Article

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

Published in:

Investigational New Drugs, 2014, v. 32, n. 5, p. 1017, doi. 10.1007/s10637-014-0111-8

By:

Ciombor, Kristen;
Feng, Yang;
Benson, Al;
Su, Yingjun;
Horton, Linda;
Short, Sarah;
Kauh, John;
Staley, Charles;
Mulcahy, Mary;
Powell, Mark;
Amiri, Katayoun;
Richmond, Ann;
Berlin, Jordan

Publication type:

Article